Genetic study on PTSD identifies new treatment targets

Summary: A groundbreaking genetic study on PTSD identified 95 genetic hotspots, 80 previously unknown, potentially leading to new therapies. PTSD affects 10% of the general population and 20-30% of high-risk groups. The study included over 1 million people, with 58,000 of non-European descent. It found 43 potential treatment target genes and identified proteins indicating PTSD susceptibility. The research aims to include more diverse populations, like those in Africa.

Full article